Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selonsertib in NASH With Bridging Fibrosis
NL-OMON47486Phase 3Active, not recruiting
- Sponsor
- Gilead Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of selonsertib, sponsored by Gilead Sciences. Started Mar 2017; status: active, not recruiting.
02
Drugs
selonsertib
Beyond the preview
Go deeper on NL-OMON47486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47486.